Public Health & Disaster Response: Nepal’s Bharatpur Hospital resumed routine services after flood victims overwhelmed its morgue, with authorities temporarily burying unidentified bodies and using forensic teams to collect DNA for later identification. Infectious Disease Watch: Philippines officials say TB medicine procurement is delayed but bids will be evaluated Sept. 3–10, with supplies possibly arriving in October/November; meanwhile, the DOH reports 3.1 million leptospirosis pills in stock for flood response. Regulation & Safety: Gujarat’s FDCA cancelled licences of 50 pharma firms and ordered closures of two units over illegal medicines, alongside a rural antibiotic quality drive. Cancer Care Access: Ottawa Hospital is closing overnight beds at Maurice Grimes Lodge for out-of-town cancer patients as part of cutbacks. Healthcare Capacity & Innovation: Guangzhou is expanding “tubeless” lung cancer surgery to more hospitals, aiming for faster recovery and earlier mobilization. Drug Discovery & Pharma Deals: Insilico Medicine released new AI models for chemistry and biology; Alteogen announced an option-and-license deal with Novartis for subcutaneous drug formulations. Clinical Outcomes: A study reports anifrolumab is linked to lower infection and hospitalization risk in chronic skin lupus. Health System Pressure: Telangana suppliers halted Aarogyasri supplies over nearly two years of unpaid dues, warning of shortages of critical equipment and medicines. Policy & Affordability: CMS proposes Medicare payment cuts for certain procedures when billed alongside separate E/M services, raising concerns about access and added visits. Community Health: Georgia Medicaid provider Amerigroup is running statewide wellness days, including diaper and ice-cream events, to connect families to resources.